Table 2.
Association of cardiometabolic risk factors and laboratory values in 2014 with RTL at follow up in 2019 and ΔRTL.
| Cardiometabolic risk factors and laboratory values in 2014 | All sample N=196 | RTL at follow-up | ΔRTL | ||
|---|---|---|---|---|---|
| Correlation (r) mean±SD | p-value | Correlation (r) mean±SD | p-value | ||
| Diabetes | |||||
| Definite Diabetes | 0.09 | 0.30 | |||
| No | 163 (83.2) | 1.22±1.06 | -0.27±1.12 | ||
| Yes | 33 (16.8) | 0.89±0.53 | -0.49±1.08 | ||
| Self-reported diabetes or hyperglycemia diagnosis | 0.16 | 0.88 | |||
| No | 169 (86.2) | 1.21±1.05 | -0.30±1.15 | ||
| Yes | 27 (13.8) | 0.93±0.54 | -0.33±0.94 | ||
| Diabetes treatment | 0.24 | 0.84 | |||
| No | 169 (86.2) | 1.20±1.05 | -0.31±1.14 | ||
| Yes | 27 (13.8) | 0.95±0.53 | -0.27±0.95 | ||
| Fasting serum glucose (mg/dL) | 0.37 | 0.138 | |||
| <100 – normal | 90 (45.9) | 1.10±0.55 | -0.44±0.96 | ||
| ≥100 – abnormal | 106 (54.1) | 1.22±1.26 | -0.20±1.23 | ||
| Insulin (μIU/mL), Mean (±SD) | 28.95±11.62 | -0.063 | 0.415 | -0.046 | 0.558 |
| HbA1c (%), Mean (±SD) | 5.9±1.2 | -0.098 | 0.170 | -0.021 | 0.768 |
| C peptide (ng/dL), Mean (±SD) | 3.18±1.37 | -0.146 | 0.044 | -0.154 | 0.033 |
| Hypertension (HTN) | |||||
| Definite HTN | |||||
| No | 127 (64.8) | 1.20±1.12 | 0.51 | -0.36±1.20 | 0.40 |
| Yes | 69 (35.2) | 1.10±0.71 | -0.22±0.95 | ||
| Self-reported HTN diagnosis | 0.26 | 0.94 | |||
| No | 159 (81.1) | 1.20±1.07 | -0.31±1.20 | ||
| Yes | 37 (18.9) | 1.00±0.57 | -0.30±1.26 | ||
| HTN treatment | 0.17 | 0.79 | |||
| No | 161 (82.1) | 1.21±1.07 | -0.30±1.14 | ||
| Yes | 35 (17.9) | 0.96±0.53 | -0.35±1.02 | ||
| Systolic Blood Pressure (mm/Hg), Mean (±SD) | 121.97±19.05 | -0.120 | 0.093 | 0.007 | 0.921 |
| Diastolic Blood Pressure (mm/Hg), Mean (±SD) | 75.73±10.28 | 0.008 | 0.908 | 0.062 | 0.388 |
| Dyslipidemia | |||||
| Self-reported dyslipidemia diagnosis | 0.83 | ||||
| No | 146 (74.5) | 1.17±1.09 | -0.36±1.20 | 0.27 | |
| Yes | 50 (25.5) | 1.14±0.65 | -0.16±0.80 | ||
| Dyslipidemia treatment | 0.11 | 0.90 | |||
| No | 156 (79.6) | 1.22±1.09 | -0.30±1.18 | ||
| Yes | 40 (20.4) | 0.94±0.08 | -0.33±0.85 | ||
| HDL (mg/dL), Mean (±SD) | 49.38±13.80 | -0.052 | 0.465 | -0.058 | 0.420 |
| LDL (mg/dL), Mean (±SD) | 111.64±36.89 | 0.040 | 0.574 | 0.098 | 0.174 |
| Triglycerides (mg/dL), Mean (±SD) | 142.18±72.41 | 0.022 | 0.763 | 0.065 | 0.369 |
| Metabolic syndrome | |||||
| Metabolic Syndrome | |||||
| No | 86 (43.9) | 1.13±0.60 | 0.62 | -0.39±1.04 | 0.35 |
| Yes | 110 (56.1) | 1.20±1.23 | -0.24±1.17 | ||
| Atherosclerotic vascular disease (ASCVD) risk | |||||
| ASCVD 10 yrs risk (%), Mean (±SD) | 7.79±7.45 | -0.133 | 0.154 | -0.075 | 0.426 |
| Other | |||||
| CRP (mg/L), Mean (±SD) | 11.77±7.27 | -0.006 | 0.934 | -0.033 | 0.649 |
| Cortisol (μg/dL), Mean (±SD) | 18.47±12.27 | -0.052 | 0.484 | 0.058 | 0.432 |
Bolded P-values are statistically significant as they are less or equal to 0.05.